Large
Molecules

Aragen supports large molecule research, development and manufacturing programmes through integrated biologics capabilities, analytical characterisation and process development expertise. Our capabilities support customer programmes across multiple stages of the development lifecycle, from early research through development and regulatory submission support, where applicable. Analytical characterisation and development workflows support programme evaluation, process understanding and development planning.

Aragen’s Biologics Development & Manufacturing platform operates on an integrated gene-to-GMP model and had an installed GMP biologics manufacturing capacity of 2.50 KL as of 31 March 2026. Since Fiscal 2019, we have delivered 54 cell lines to customers.